Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
Submitted by
admin
on September 5, 2012 - 12:51pm
Source:
Forbes
News Tags:
Alexion
Soliris
anemia
Headline:
How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse
Do Not Allow Advertisers to Use My Personal information
